Novem Group S.A.
/ Key word(s): IPO
NOT FOR DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS ARE APPLICABLE. PLEASE SEE THE IMPORTANT DISCLAIMER AT THE END OF THIS RELEASE. Press Release Novem Group sets final price for private placement at EUR 16.50 per share - Successful placement of 14,984,848 shares to international institutional investors - Total private placement volume of EUR 247.2 million - Novem raises primary gross proceeds of EUR 50 million to optimize its capital structure and refinance liabilities - First trading day on the regulated market of the Frankfurt Stock Exchange (Prime Standard) is scheduled for 19 July 2021
Günter Brenner, CEO der Novem Group: "We are very pleased about the high level of interest shown by institutional investors during our roadshow. We take it as a clear sign that Novem's Listing comes at the right time and that our investors support Novem's growth plans. The trust placed in us encourages and motivates us to continue to pursue this path and expand our leading market position." 3,030,303 newly issued shares from a cash capital increase (the "New Shares") have been placed. The corresponding primary gross proceeds of EUR 50 million will be used to optimize Novem's capital structure and refinance liabilities to achieve a reduction of relevant interest rates. In addition, 10,000,000 existing shares (the "Base Shareholder Shares" and together with the New Shares, the "Base Shares") have been placed from the holdings of Rokoko Automotive Holdings (Jersey) Limited (the "Selling Shareholder"), an entity controlled by funds advised by family backed investor Bregal. In addition, 1,954,545 shares have been allocated in connection with an over-allotment. The total offering size amounts to EUR 247.2 million (including the over-allotment). As part of the private placement, a long-only institutional investor and the holding company of the Brenninkmeijer family entrepreneurs have placed orders. The Company is considering to allocate up to 3,000,000 shares to such long-only institutional investor and up to 4,425,000 shares to the holding company of the Brenninkmeijer family entrepreneurs in order to partly accept their respective orders. Members of management holding shares have committed to a lock-up period of 720 days. The Company and the two existing shareholders are subject to a lock-up of 180 days. The approval of the listing prospectus by the Luxembourg Financial Supervisory Authority (Commission de Surveillance du Secteur Financier or "CSSF") is anticipated on or about 15 July 2021. After the approval, the prospectus, will be available on Novem's website https://novem.com/ in the "Investor Relations" section. Trading in the Company's shares on the Regulated Market (Prime Standard) of the Frankfurt Stock Exchange is expected to commence on 19 July 2021 under the trading code NVM, the international securities identification number (ISIN) LU2356314745 and WKN: A3CSWZ. J.P. Morgan, Berenberg, COMMERZBANK are acting as Joint Global Coordinators, Jefferies and UniCredit are acting as Joint Bookrunners for the transaction. About Novem For more information please visit www.novem.com Media contacts Harald Kinzler Novem Group S.A. | 19, rue Edmond Reuter, L-5326 Contern | Luxembourg DISCLAIMER In member states of the European Economic Union and the United Kingdom, any offering mentioned in this publication will only be addressed to and directed at persons who are "qualified investors" within the meaning of Article 2(e) of Regulation (EU) 2017/1129, in the case of the United Kingdom, as it forms part of domestic law by virtue of the European Union (Withdrawal) Act 2018. In addition, in the United Kingdom, this document is only being distributed to and is only directed at persons who (i) are investment professionals falling within Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005, as amended (the "Order"), (ii) are persons falling within Article 49(2)(a) to (d) of the Order (high net worth companies, unincorporated associations, etc.), or (iii) are persons to whom an invitation or inducement to engage in investment activity (within the meaning of section 21 of the Financial Services and Markets Act 2000) in connection with the issue or sale of any securities may otherwise lawfully be communicated or caused to be communicated (all such persons together being referred to as "Relevant Persons"). This document is directed only at Relevant Persons and must not be acted on or relied on by persons who are not Relevant Persons. Any investment or investment activity to which this document relates is available only to Relevant Persons and will be engaged in only with Relevant Persons. Certain statements contained in this release may constitute "forward-looking statements" that involve a number of risks and uncertainties. Forward-looking statements are generally identifiable by the use of the words "may", "will", "should", "plan", "expect", "anticipate", "estimate", "believe", "intend", "project", "goal" or "target" or the negative of these words or other variations on these words or comparable terminology. Forward-looking statements are based on assumptions, forecasts, estimates, projections, opinions or plans that are inherently subject to significant risks, as well as uncertainties and contingencies that are subject to change. No representation is made or will be made by the Company that any forward-looking statement will be achieved or will prove to be correct. The actual future business, financial position, results of operations and prospects may differ materially from those projected or forecast in the forward-looking statements. Neither the Company nor any of the underwriters nor any of their respective affiliates nor any other person assume any obligation to update, and do not expect to publicly update, or publicly revise, any forward-looking statements or other information contained in this release, whether as a result of new information, future events or otherwise, except as otherwise required by law. This announcement also contains certain financial measures that are not recognized under International Financial Reporting Standards ("IFRS"). These non-IFRS measures are presented because the Company believes that they and similar measures are widely used in the markets in which it operates as a means of evaluating the Company's operating performance and financing structure. They may not be comparable to other similarly titled measures of other companies and are not measurements under IFRS or other generally accepted accounting principles. In connection with the placement of the shares in the Company, J.P. Morgan AG, acting for the account of the underwriters, will act as stabilization manager (the "Stabilization Manager") and may, as Stabilization Manager, make overallotments and take stabilization measures in accordance with Article 5(4) and (5) of the Regulation (EU) No 596/2014 of the European Parliament and of the Council of April 16, 2014 on market abuse, as amended, in conjunction with Articles 5 through 8 of Commission Delegated Regulation (EU) 2016/1052) of March 8, 2016. Stabilization measures aim at supporting the market price of the shares of the Company during the stabilization period, such period starting on the date the Company's shares commence trading on the regulated market (Prime Standard) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse), expected to be July 19, 2021, and ending no later than 30 calendar days thereafter (the "Stabilization Period"). Stabilization transactions may result in a market price that is higher than would otherwise prevail. However, the Stabilization Manager is under no obligation to take any stabilization measures. Stabilization transactions may be effected on the Frankfurt Stock Exchange, in the over-the-counter market or otherwise. In connection with such stabilization measures, investors may be allocated additional shares of the Company of up to 15% of the new and existing shares actually placed in the private placement (the "Over-allotment Shares"). The selling shareholders granted the Stabilization Manager, acting for the account of the underwriters, an option to acquire a number of shares in the Company equal to the number of Over-allotment Shares at the offer price, less agreed commissions (so-called Greenshoe option). THIS DOCUMENT IS NOT A PROSPECTUS BUT AN ADVERTISEMENT AND INVESTORS SHOULD NOT SUBSCRIBE FOR OR PURCHASE ANY SHARES REFERRED TO IN THIS ADVERTISEMENT EXCEPT ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS.
15.07.2021 Dissemination of a Corporate News, transmitted by DGAP - a service of EQS Group AG. |
Language: | English |
Company: | Novem Group S.A. |
19, rue Edmond Reuter | |
L-5326 Contern | |
Luxemburg | |
ISIN: | LU2356314745 |
WKN: | A3CSWZ |
EQS News ID: | 1218970 |
Börsennotierung im Prime Standard vorgesehen / intended to be listed. |
End of News | DGAP News Service |
|
1218970 15.07.2021
up